Steve Schonfeld’s Latigo Biotherapeutics LTGO Stock Holding History
Bought
Maintained
Sold
Other funds holding LTGO
Steve Schonfeld's LTGO Position: Q3 2026 in Review
Steve Schonfeld opened a new position in Latigo Biotherapeutics (LTGO) in Q3 2026: 25,896 shares worth $432K. The stake represents ﹤0.01% of the portfolio and ranks #2036 among its holdings.
58 funds tracked by Wall St. Rank hold LTGO as of Q3 2026.
- Steve Schonfeld held 25,896 shares of Latigo Biotherapeutics worth $432K as of Q3 2026.
- Latigo Biotherapeutics was a new Steve Schonfeld position in Q3 2026.
- Latigo Biotherapeutics made up ﹤0.01% of Steve Schonfeld's portfolio in Q3 2026, its #2036 holding.
- 58 funds tracked by Wall St. Rank held Latigo Biotherapeutics as of Q3 2026.
Based on Schonfeld Strategic Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.